摘要
食管癌根治术后并发症的发生率高达20%~50%,其中肺部并发症是食管癌术后最常见的和导致围术期死亡最多的并发症。在诸多影响食管癌术后并发症发生的因素中,食管癌术中及术后补液量与术后并发症的发生密切相关。而且在加速康复外科(enhanced recovery after surgery,ERAS)的大环境下,优化食管癌术后液体管理显得更加重要。限制性液体治疗在食管癌患者术后扮演着越来越重要的角色。本综述希望能综合相关研究成果,就限制性补液方案相对其它补液方案有何优势、限制性输液的输液量和输液速度、如何在补液过程中进行监测评估以及输液种类的选择等几方面进行探讨,以供临床借鉴参考。
The incidence of complications after radical resection of esophageal carcinoma is high up to about20%-50%.The incidence of pneumonia,pleural effusion,tracheal intubation,anastomotic fistula and cardiac events is relatively high.Among them,pulmonary complications are the most common complications after esophageal cancer operation and cause the most perioperative deaths.Among the factors that influence the occurrence of postoperative complications of esophageal cancer,the amount of fluid infusion during and after the operation is closely related to the occurrence of postoperative complications.Moreover,in the environment of enhanced recovery after surgery(ERAS),it is more important to optimize the postoperative fluid management of esophageal cancer.Restricted fluid therapy plays a more and more important role in patients undergoing esophagectomy.This review integrated the relevant research results and discussed the advantages of the restricted fluid therapy compared with other fluid therapy,how to control the restricted infusion volume and infusion speed and how to monitor and evaluate the infusion process and the selection of infusion types,so as to provide reference for clinical practice test.
作者
杜彦霖
崔永
DU Yanlin;CUI Yong(Department of Thoracic Surgery,Beijing Friendship Hospital,Capital Medical University,Beijing,100050,P.R.China)
出处
《中国胸心血管外科临床杂志》
CSCD
北大核心
2022年第2期257-261,共5页
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
关键词
食管癌
围手术期
液体治疗
综述
Esophageal cancer
perioperative period
fluid therapy
review
